Patent · US Active

Novel, heavy vitamin B12 derivatives

US12344630B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 6, 2023
Grant dateJul 1, 2025
Priority date
Expiry dateDec 6, 2043

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention discussed in this application relates to vitamin B12-based compounds that are useful as quantitative standards, particularly for the assessment of vitamin B12 deficiency.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.